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Intr
Mortality among leukemia patients admitted to the inten-
sive care units remain high [1] and bleeding complications
are common in these patients [2]. Prediction of bleeding
would be of value because bleeding may associate with
mortality. In recent years there has also been increasing
focus on thrombosis among leukemia patients [3].
Objectives
The basis for this study was a clinical observation of a high
frequency of bleeding complications among ICU patients
with leukaemia. We wanted to answer the following
questions:
1. How big is the problem?
2. Can we predict bleeding or thrombosis using standard
laboratory coagulation tests?
3. Is bleeding and/or thrombosis associated with a
higher ICU-mortality?
Methods
Retrospective observational study of patients with
AML, ALL or MDS admitted to the ICU at Copenhagen
University Hospital 2008-12. Data was collected from
the ICU electronic patient files, the National Blood
Bank as well as the hospital’s clinical chemistry labora-
tory database. Bleeding complications were graded
according to the WHO classification.
Results
There was a high frequency of bleeding among these
patients:
- 66 patients (57%) had one or several bleeding episodes
during their ICU stay
- More than half of the bleedings were severe or debilitat-
ing (WHO grade 3-4)
- One third of all the admitted patients had at least
one major bleeding episode during their ICU stay
- 10 deaths were directly related to bleeding episodes
- 11 patients (9%) had thrombi clinically or on ultra-
sound/CT-scan
Among severely thrombocytopenic patients (b-platelets
< 50x109/L) there was no difference among bleeders and
non-bleeders with regard to platelet numbers, INR levels,
activated pro-thrombin time, fibrinogen concentrations
and anti-thrombin levels.
Higher 30-day mortality rates were observed in bleeding
vs non-bleeding patients (68% vs 50%, p = 0.19.)
Conclusions
Bleeding was very common and associated with mortality
in leukaemia patients in the ICU, but it was difficult to
predict in the individual patient using traditional coagula-
tion analyses.
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